ES2032091T3 - Procedimiento para la obtencion de hidroxipropanfenol-gliceridos. - Google Patents

Procedimiento para la obtencion de hidroxipropanfenol-gliceridos.

Info

Publication number
ES2032091T3
ES2032091T3 ES198989118046T ES89118046T ES2032091T3 ES 2032091 T3 ES2032091 T3 ES 2032091T3 ES 198989118046 T ES198989118046 T ES 198989118046T ES 89118046 T ES89118046 T ES 89118046T ES 2032091 T3 ES2032091 T3 ES 2032091T3
Authority
ES
Spain
Prior art keywords
glycerides
hydroxypropanphenol
procedure
obtaining
image
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989118046T
Other languages
English (en)
Inventor
Joerg Dr. Rosenberg
Juergen Heberger
Dr. Gruenhagen Hans-Heinrich
Egon Dr. Brode
Gerda Dr. Von Philipsborn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Application granted granted Critical
Publication of ES2032091T3 publication Critical patent/ES2032091T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/36—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE DESCRIBEN HIDROXIPROPAFENIONGLICERIDOS CON FORMULA I DONDE R ES UN RESTO N - PROPIL O 1,1-DIMETILPROPIL; X ES EL NUMERO 2 O 3; Y LOS NUMEROS 12, 14, 15, 18 O 20; A Y B SON DIFERENTES ENTRE SI Y SIGNIFICAN EL 0 O1. SE DESCRIBEN TAMBIEN SUS ESTEREOISOMEROS Y SU ELABORACION. LOS COMPUESTOS SON ADECUADOS COMO SUSTANCIAS ACTIVAS PARA ANTIRREUMATICOS.
ES198989118046T 1988-10-07 1989-09-29 Procedimiento para la obtencion de hidroxipropanfenol-gliceridos. Expired - Lifetime ES2032091T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3834132A DE3834132A1 (de) 1988-10-07 1988-10-07 Hydroxypropafenonglyceride

Publications (1)

Publication Number Publication Date
ES2032091T3 true ES2032091T3 (es) 1993-01-01

Family

ID=6364587

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989118046T Expired - Lifetime ES2032091T3 (es) 1988-10-07 1989-09-29 Procedimiento para la obtencion de hidroxipropanfenol-gliceridos.

Country Status (6)

Country Link
US (1) US4958046A (es)
EP (1) EP0362707B1 (es)
JP (1) JPH02209852A (es)
AT (1) ATE76061T1 (es)
DE (2) DE3834132A1 (es)
ES (1) ES2032091T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3907512C2 (de) * 1989-03-08 1997-08-14 Laevosan Gmbh & Co Kg Neue Aryloxy-alkylamine, deren Herstellung und diese enthaltende Arzneimittel
JP6749890B2 (ja) * 2014-08-12 2020-09-02 モナッシュ ユニバーシティ リンパ指向プロドラッグ
CN118063537A (zh) 2015-09-08 2024-05-24 莫纳什大学 定向淋巴的前药
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
US11304954B2 (en) 2017-12-19 2022-04-19 Puretech Lyt, Inc. Lipid prodrugs of mycophenolic acid and uses thereof
US11608345B1 (en) 2017-12-19 2023-03-21 Puretech Lyt, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
AU2021217172A1 (en) 2020-02-05 2022-09-22 Monash University Lipid prodrugs of neurosteroids

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3226863A1 (de) * 1981-09-18 1983-04-07 Basf Ag, 6700 Ludwigshafen Aminopropanolderivate von 2-hydroxy-ss-phenyl-propiophenonen, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
EP0077529B1 (de) * 1981-10-16 1985-07-17 Sanol Schwarz GmbH Arzneimittelformulierung

Also Published As

Publication number Publication date
EP0362707B1 (de) 1992-05-13
DE3834132A1 (de) 1990-04-12
US4958046A (en) 1990-09-18
ATE76061T1 (de) 1992-05-15
JPH02209852A (ja) 1990-08-21
EP0362707A1 (de) 1990-04-11
DE58901409D1 (en) 1992-06-17

Similar Documents

Publication Publication Date Title
ES2036199T3 (es) Procedimiento de obtencion de un preparado farmaceutico administrable a traves de una membrana corporal.
ES538757A0 (es) Procedimiento para la preparacion de 11b-aril-estradienos
NO871640D0 (no) Fremgangsmaate for fremstilling av n-(2[-aminofenyl)-benzamidderivater.
NO821018L (no) Analogifremgangsmaate for fremstilling av bispidinderivater
ES2032091T3 (es) Procedimiento para la obtencion de hidroxipropanfenol-gliceridos.
JPS57140756A (en) N-benzoyl-n'-phenylurea, manufacture and insecticide containing same as effective component
ATE120446T1 (de) Substituierte acrylsäureester.
ES2045235T3 (es) Fungicidas que contienen compuestos de guanidinio y procedimiento para la lucha contra los hongos.
ES557620A0 (es) Procedimiento para la obtencion de s.s.-dioxido dce 3-acetilamino-4-metoxibenzoisotiazol.
PT98268A (pt) Processo para a preparacao de indano-pirrolidino-carbamatos
FI910059A0 (fi) Kemiska foereningar.
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
FI906162A0 (fi) Foerfarande foer framstaellning av 3-(n-metyl-n-alkyl)-amino-2-metoximetylenpropan-1-olderivat.
GB2251613A (en) Substituted phenylsulphonyltriazinylurea and salts thereof and means for stimulating and suppressing plant growth based on them
DE3467161D1 (de) Unsaturated arylalkyl ammonium salts
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
NO890287L (no) Fremstilling av beta-laktam-antibiotika.
FI873483A0 (fi) Oxiranpseudooligosackarider, foerfarande foer deras framstaellning, deras anvaendning och farmaceutiska preparat.
IT1129278B (it) Procedimento per la preparazione di 2 osso diidrobenzo (d)(1,3) ossazione
NO903585L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksaziner.
ATE11669T1 (de) Vasodilator, verfahren zur herstellung und arzneimittelzusammensetzungen.
MX9100343A (es) Procedimiento para la preparacion de analogos 6-acilo,7-acilo y 6,7-diacilo de forscolina y sus compuestos intermedios
ES2070932T3 (es) Derivado de imidazolilpropilguanidina, procedimiento para su preparacion y medicamentos que lo contienen.
ES554120A0 (es) Procedimiento para la obtencion de esteres de acidos 3-(2,2-dihalovinil)-2,2-dimetilciclppropanocarboxilicos
ES2037116T3 (es) Procedimiento para la obtencion de bencilaminoarildihidropiridinlactonas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 362707

Country of ref document: ES